JNE Partners LLP - Q3 2021 holdings

$177 Million is the total value of JNE Partners LLP's 13 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 36.4% .

 Value Shares↓ Weighting
UHAL  AMERCO$32,835,000
+9.6%
50,8260.0%18.52%
-15.8%
CMCSA  COMCAST CORP NEWcl a$31,427,000
-1.9%
561,9020.0%17.72%
-24.6%
CP NewCANADIAN PAC RY LTD$19,931,000306,300
+100.0%
11.24%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$16,685,000112,700
+100.0%
9.41%
MSDAU  MSD ACQUISITION CORPunit 03/25/2026$15,015,000
-0.9%
1,500,0000.0%8.47%
-23.9%
ORIAU  ORION BIOTECH OPPORTUNTES COunit 04/15/2025$14,851,000
-1.5%
1,500,0000.0%8.37%
-24.3%
NG  NOVAGOLD RES INC$13,451,000
-14.1%
1,955,0470.0%7.58%
-34.0%
EOCWU  ELLIOTT OPPORTUNITY II CORPunit 99/99/9999$11,132,000
+1.1%
1,100,0000.0%6.28%
-22.3%
WALD  WALDENCAST ACQUISITION CORP$9,800,000
-1.5%
1,000,0000.0%5.53%
-24.3%
BATRK NewLIBERTY MEDIA CORP DEL$5,337,000202,000
+100.0%
3.01%
RKTAU  ROCKET INTERNET GRWT OPRT COunit 99/99/9999$4,294,000
-0.3%
430,2340.0%2.42%
-23.4%
KAHCU  KKR ACQUISITION HOLDING I COunit 99/99/9999$2,294,000
-0.6%
229,8660.0%1.29%
-23.6%
WALDW  WALDENCAST ACQUISITION CORP*w exp 03/11/202$287,000
-21.8%
333,3330.0%0.16%
-39.8%
LMACA ExitLIBERTY MEDIA ACQUISITION CO$0-42,126
-100.0%
-0.32%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings